CXCL12 and prostate carcinoma: Specifically, CXCL12/CXCR4 signaling axis in prostate cancer bone metastasis (the main site of prostate cancer dissemination) participates in the formation of the endosteal niche, and blocking this axis compromises initial establishment of tumors in the bone microenvironment.